[1]
Simioni, C. et al. 2017. Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway and NUP214-ABL1 fusion protein in human acute lymphoblastic leukemia. Italian Journal of Anatomy and Embryology. 121, 1 (Oct. 2017), 127.